This inventor holds 3 USPTO granted patents. Top assignee: University of Pennsylvania. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2015
Title: **The Innovative Mind of Joel S Bennett: A Pioneer in Integrin Inhibitors**
Introduction
Joel S Bennett, based in Bryn Mawr, Pennsylvania, is a distinguished inventor who has made significant contributions to the field of biochemistry and pharmacology. With a remarkable portfolio of 3 patents, he focuses on the development of novel compounds that target integrin receptors, which play crucial roles in various biological processes.
Latest Patents
Among his notable innovations are two latest patents that emphasize inhibitors of the integrin alpha2beta1/GPIa-IIa receptor. The first patent details a new class of compounds based on prolyl diaminopropionic acid scaffold, aimed at inhibiting the integrin α2β1/GPIa-IIa-mediated activity. This advanced pharmaceutical composition is described not only for its effectiveness but also for its therapeutic applications. Similarly, his second patent reiterates the significance of these novel compounds in obstructing the same integrin receptor, thereby advancing the potential for effective treatments in related medical scenarios.
Career Highlights
Currently affiliated with the University of Pennsylvania, Bennett has established himself as a leading figure in his area of expertise. His work primarily revolves around the intricate mechanisms of integrin receptors and their impact on health and disease.
Collaborations
Bennett collaborates with talented coworkers, including Sungwook Choi and William F DeGrado. Together, they contribute to advancing research and fostering innovation in their respective fields, as they explore the therapeutic potentials of integrin inhibitors.
Conclusion
In summary, Joel S Bennett's journey as an inventor showcases his dedication to pioneering innovative solutions in the healthcare sector. His patents on integrin inhibitors not only mark a significant achievement in biomedical research but also hold promise for therapeutic advancements that could benefit countless individuals. Through his work at the University of Pennsylvania, Bennett continues to inspire the next generation of inventors and researchers in the vast realm of scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile